Decriminalization Policy Therapy Treatment 
Veriheal
DECEMBER 15, 2023
MAPS Public Benefit Corporation (PBC), an arm of the Multidisciplinary Association for Psychedelic Studies , has made big strides recently encouraging the Food and Drug Administration (FDA) to consider approving MDMA, also known as molly or ecstasy, for MDMA-assisted therapy.
Cannabis Law Report
SEPTEMBER 23, 2022
Senate Bill 519 would have decriminalized the personal possession of certain psychedelic substances, legalized life-saving public health interventions, and studied future approaches to increasing use of psychedelics. However, the Assembly Appropriations Committee stripped the primary intention from the bill.
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Veriheal
OCTOBER 13, 2023
If approved, the bill would decriminalize psychedelics for personal use and noncommercial activities like cultivation, provided there is no monetary exchange involved. Along with their medical properties, psychedelics’ low potential for abuse and psychological harm means legalization is just “good public policy” Sen. Irwin says.
Cannabis Law Report
FEBRUARY 9, 2022
Food and Drug Administration designated psilocybin as a breakthrough treatment for drug-resistant depression in 2018 and for major depressive disorder in 2019. It’s an important discussion,” Meyer said of the treatment option. This is a breakthrough therapy and it shows promise, but the science is not there yet.”.
Veriheal
MARCH 20, 2023
Alternative medicine is becoming more widely acknowledged and practiced than ever before, opening the door for therapies like psychedelics to enter the world of mainstream healthcare. Psilocybin therapy is both studied and used by highly legitimate medical establishments. Ned Lamont signed a bill (HB 5506) to fund psychedelic therapy.
Cannabis Law Report
JULY 1, 2021
The Petrie-Flom Center for Health Law Policy, Biotechnology, and Bioethics at Harvard Law School is engaged in a three-year initiative to examine the ethical, legal, and social implications of psychedelics research, commerce, and therapeutics. While psychedelic therapies make their way through the drug development pipeline, seven U.S.
Cannabis Law Report
AUGUST 10, 2021
As psychedelic therapy trials approach FDA approval, researchers express the urgent need to ensure effectiveness and accessibility to communities of color. Madison Natarajan, MS. – August 5, 2021.
Expert insights. Personalized for you.
104 
Let's personalize your content